Funding Opportunities in The Netherlands & India

---

Dr. Ram Siddappa is an Investment Manager at Libertatis Ergo Holding B.V. (LEH) an independent, wholly owned subsidiary of Leiden University & Medical Center which creates, supports and invests in companies related to Leiden University’s and Medical Center’s activities, many of which are located on the Leiden Bio Science Park. LEH currently supports over 40 startup and spinout companies aimed at increasing the impact of Leiden University. LEH holds the patent portfolio of the University, and patent management services are outsourced to the LURIS, the Technology Transfer Office of Leiden University. LEH works across Leiden University and with many external organizations, incubators, foundations and investors to guide, structure, finance, and develop entrepreneurship activities and startups.

Selected Portfolio Companies (As an Investor, Board Member, or Advisor)

• Kaminari Medical B.V. Intravascular PhotoAcoustic + Ultrasound Imaging system for cardiovascular risk detection and therapy: Erasmus MC technology. Member, Board of Directors.
• Levels Diagnostics B.V. – Biomarker discovery platform targeting infectious diseases and oncology. Technology licensed from LUMC, Member, Board of Directors.
• Pelagen B.V. Tissue-engineered lab-grown leather and wool from an in vitro skin model from technology licensed from LUMC
• AVP Device B.V.  Novel Aortic Valve Repair device technology licensed from LUMC
• Methylomics B.V Epigenetic onco-diagnostic technology licensed from Erasmus MC for cancer detection and therapy.
• Numeric Biotech B.V. – Pioneering skin longevity by targeting senescent cells for healthy ageing. Licensed from Erasmus MC
• Quantib B.V. – An Image processing method and system for quantitative imaging for AI and Image-guided therapy. Multiple licenses for Artificial Intelligence and Image-guided therapy in the healthcare sector. Technology licensed from Erasmus MC.
• Secupad B.V.- A MedTech device for early detection and therapy for diabetic foot ulcer, technology licensed and validated at LUMC
• StemX Bio B.V.- A diabetic drug discovery project using micro and organoid models, technology licensed from LUMC.

Dr. Ram Siddappa, PhD, MBA 

Investment Manager, Life Science & Health Startups  

RTTP-Certified Licensing Professional 

Libertatis Ergo Holding B.V. BioPartner 3, Leiden Bio  Science Park,

Galileiweg 8, 2333 BD, Leiden,  https://libertatisergo.com

📧: r.siddappa@LEH.leidenuniv.nl